Synergistic Prostate Cancer Treatment System

Publication ID: 24-11857243_0003_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Prostate Cancer Treatment System,” Published Technical Disclosure No. 24-11857243_0003_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857243_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,243.

Summary of the Inventive Concept

A novel system integrating heated condensable vapor technology with AI, IoT, blockchain, and machine learning to enhance prostate cancer treatment efficacy and patient outcomes.

Background and Problem Solved

The original patent's heated condensable vapor technology has limitations in optimizing treatment parameters, tracking patient outcomes, and ensuring data integrity. The new inventive concept addresses these limitations by synergistically combining the vapor technology with advanced technologies to create a more powerful and effective system.

Detailed Description of the Inventive Concept

The system comprises a vapor delivery device connected to an AI-powered vapor generator that optimizes vapor temperature and flow rate based on real-time tissue impedance feedback. The system integrates a blockchain-based patient data management system to track and verify treatment efficacy and patient outcomes. A needle-like vapor delivery device with a built-in IoT sensor monitors and transmits real-time treatment data to a remote monitoring station. The system also incorporates a machine learning algorithm that predicts optimal treatment parameters based on individual patient characteristics and medical history. Additionally, a novel nano-material based vapor generator enhances vapor temperature and stability, and is integrated with a real-time monitoring system.

Novelty and Inventive Step

The new claims introduce a synergistic combination of advanced technologies that significantly enhance the original patent's heated condensable vapor technology. The inventive step lies in the integration of AI, IoT, blockchain, and machine learning to create a more effective and personalized prostate cancer treatment system.

Alternative Embodiments and Variations

Alternative embodiments could include using different AI algorithms, integrating with other medical devices, or incorporating additional sensors to monitor treatment efficacy. Variations could include adapting the system for treating other types of cancer or using different vapor delivery mechanisms.

Potential Commercial Applications and Market

The Synergistic Prostate Cancer Treatment System has significant commercial potential in the medical device industry, particularly in the areas of cancer treatment and personalized medicine. The system's ability to enhance treatment efficacy, track patient outcomes, and ensure data integrity could lead to widespread adoption in hospitals and clinics.

CPC Classifications

SectionClassGroup
A A61 A61B18/042
A A61 A61B8/0841
A A61 A61B18/04
A A61 A61B2018/00005
A A61 A61B2018/00011
A A61 A61B2018/00017
A A61 A61B2018/00023
A A61 A61B2018/00101
A A61 A61B2018/00547
A A61 A61B2018/00577
A A61 A61B2018/00642
A A61 A61B2018/00702
A A61 A61B2018/00744
A A61 A61B2018/00791
A A61 A61B2018/00821
A A61 A61B2018/044
A A61 A61B2018/048
A A61 A61B2090/378
A A61 A61B2090/3784
A A61 A61B2218/007

Original Patent Information

Patent NumberUS 11,857,243
TitleSystems and methods for treating prostate cancer
Assignee(s)Boston Scientific Scimed, Inc.